FPR2 and cystic fibrosis: Focusing on lipid mediators, the ALX/FPR2-dependent pathway, activated by lipoxin LXA4 and resolvin RvD1 and implicated in inflammation resolution, is altered by the increased synthesis of miR-181b in CF lung cells and macrophages (Table 2) [138].